Complement protein C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma
Complement component C1q can act as a pro-tumorigenic factor in the tumor microenvironment (TME). The TME in malignant pleural mesothelioma (MPM) is rich in C1q and hyaluronic acid (HA), whose interaction enhances adhesion, migration and proliferation of malignant cells. HA-bound C1q is also capable...
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-06-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1151194/full |
_version_ | 1797813742861287424 |
---|---|
author | Andrea Balduit Romana Vidergar Paola Zacchi Alessandro Mangogna Chiara Agostinis Micaela Grandolfo Cristina Bottin Francesco Salton Paola Confalonieri Andrea Rocca Fabrizio Zanconati Fabrizio Zanconati Marco Confalonieri Uday Kishore Berhane Ghebrehiwet Roberta Bulla |
author_facet | Andrea Balduit Romana Vidergar Paola Zacchi Alessandro Mangogna Chiara Agostinis Micaela Grandolfo Cristina Bottin Francesco Salton Paola Confalonieri Andrea Rocca Fabrizio Zanconati Fabrizio Zanconati Marco Confalonieri Uday Kishore Berhane Ghebrehiwet Roberta Bulla |
author_sort | Andrea Balduit |
collection | DOAJ |
description | Complement component C1q can act as a pro-tumorigenic factor in the tumor microenvironment (TME). The TME in malignant pleural mesothelioma (MPM) is rich in C1q and hyaluronic acid (HA), whose interaction enhances adhesion, migration and proliferation of malignant cells. HA-bound C1q is also capable of modulating HA synthesis. Thus, we investigated whether HA-C1q interaction would affect HA degradation, analyzing the main degradation enzymes, hyaluronidase (HYAL)1 and HYAL2, and a C1q receptor candidate. We first proceeded with the characterization of HYALs in MPM cells, especially HYAL2, since bioinformatics survival analysis revealed that higher HYAL2 mRNA levels have an unfavorable prognostic index in MPM patients. Interestingly, Real-Time quantitative PCR, flow cytometry and Western blot highlighted an upregulation of HYAL2 after seeding of primary MPM cells onto HA-bound C1q. In an attempt to unveil the receptors potentially involved in HA-C1q signaling, a striking co-localization between HYAL2 and globular C1q receptor/HABP1/p32 (gC1qR) was found by immunofluorescence, surface biotinylation and proximity ligation assays. RNA interference experiments revealed a potentially regulatory function exerted by gC1qR on HYAL2 expression, since C1QBP (gene for gC1qR) silencing unexpectedly caused HYAL2 downregulation. In addition, the functional blockage of gC1qR by a specific antibody hindered HA-C1q signaling and prevented HYAL2 upregulation. Thus, C1q-HA interplay is responsible for enhanced HYAL2 expression, suggesting an increased rate of HA catabolism and the release of pro-inflammatory and pro-tumorigenic HA fragments in the MPM TME. Our data support the notion of an overall tumor-promoting property of C1q. Moreover, the overlapping localization and physical interaction between HYAL2 and gC1qR suggests a potential regulatory effect of gC1qR within a putative HA-C1q macromolecular complex. |
first_indexed | 2024-03-13T07:56:18Z |
format | Article |
id | doaj.art-9a6b8f6959214d31bd734cc79ae1ce91 |
institution | Directory Open Access Journal |
issn | 1664-3224 |
language | English |
last_indexed | 2024-03-13T07:56:18Z |
publishDate | 2023-06-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Immunology |
spelling | doaj.art-9a6b8f6959214d31bd734cc79ae1ce912023-06-02T04:37:29ZengFrontiers Media S.A.Frontiers in Immunology1664-32242023-06-011410.3389/fimmu.2023.11511941151194Complement protein C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesotheliomaAndrea Balduit0Romana Vidergar1Paola Zacchi2Alessandro Mangogna3Chiara Agostinis4Micaela Grandolfo5Cristina Bottin6Francesco Salton7Paola Confalonieri8Andrea Rocca9Fabrizio Zanconati10Fabrizio Zanconati11Marco Confalonieri12Uday Kishore13Berhane Ghebrehiwet14Roberta Bulla15Institute for Maternal and Child Health, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Burlo Garofolo, Trieste, ItalyDepartment of Life Sciences, University of Trieste, Trieste, ItalyDepartment of Life Sciences, University of Trieste, Trieste, ItalyInstitute for Maternal and Child Health, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Burlo Garofolo, Trieste, ItalyInstitute for Maternal and Child Health, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Burlo Garofolo, Trieste, ItalyNeuroscience Area, International School for Advanced Studies (SISSA), Trieste, ItalyDepartment of Medical, Surgical and Health Science, University of Trieste, Trieste, ItalyDepartment of Medical, Surgical and Health Science, University of Trieste, Trieste, ItalyDepartment of Medical, Surgical and Health Science, University of Trieste, Trieste, ItalyDepartment of Medical, Surgical and Health Science, University of Trieste, Trieste, ItalyDepartment of Medical, Surgical and Health Science, University of Trieste, Trieste, ItalyStruttura Complessa di Anatomia ed Istologia Patologica, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), Trieste, ItalyDepartment of Medical, Surgical and Health Science, University of Trieste, Trieste, ItalyDepartment of Veterinary Medicine, United Arab Emirates University, Al Ain, United Arab EmiratesDepartment of Medicine, Stony Brook University, Stony Brook, NY, United StatesDepartment of Life Sciences, University of Trieste, Trieste, ItalyComplement component C1q can act as a pro-tumorigenic factor in the tumor microenvironment (TME). The TME in malignant pleural mesothelioma (MPM) is rich in C1q and hyaluronic acid (HA), whose interaction enhances adhesion, migration and proliferation of malignant cells. HA-bound C1q is also capable of modulating HA synthesis. Thus, we investigated whether HA-C1q interaction would affect HA degradation, analyzing the main degradation enzymes, hyaluronidase (HYAL)1 and HYAL2, and a C1q receptor candidate. We first proceeded with the characterization of HYALs in MPM cells, especially HYAL2, since bioinformatics survival analysis revealed that higher HYAL2 mRNA levels have an unfavorable prognostic index in MPM patients. Interestingly, Real-Time quantitative PCR, flow cytometry and Western blot highlighted an upregulation of HYAL2 after seeding of primary MPM cells onto HA-bound C1q. In an attempt to unveil the receptors potentially involved in HA-C1q signaling, a striking co-localization between HYAL2 and globular C1q receptor/HABP1/p32 (gC1qR) was found by immunofluorescence, surface biotinylation and proximity ligation assays. RNA interference experiments revealed a potentially regulatory function exerted by gC1qR on HYAL2 expression, since C1QBP (gene for gC1qR) silencing unexpectedly caused HYAL2 downregulation. In addition, the functional blockage of gC1qR by a specific antibody hindered HA-C1q signaling and prevented HYAL2 upregulation. Thus, C1q-HA interplay is responsible for enhanced HYAL2 expression, suggesting an increased rate of HA catabolism and the release of pro-inflammatory and pro-tumorigenic HA fragments in the MPM TME. Our data support the notion of an overall tumor-promoting property of C1q. Moreover, the overlapping localization and physical interaction between HYAL2 and gC1qR suggests a potential regulatory effect of gC1qR within a putative HA-C1q macromolecular complex.https://www.frontiersin.org/articles/10.3389/fimmu.2023.1151194/fullhyaluronic acidhyaluronidaseC1qHYAL2gC1qR/HABP1/p32reactive oxygen species |
spellingShingle | Andrea Balduit Romana Vidergar Paola Zacchi Alessandro Mangogna Chiara Agostinis Micaela Grandolfo Cristina Bottin Francesco Salton Paola Confalonieri Andrea Rocca Fabrizio Zanconati Fabrizio Zanconati Marco Confalonieri Uday Kishore Berhane Ghebrehiwet Roberta Bulla Complement protein C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma Frontiers in Immunology hyaluronic acid hyaluronidase C1q HYAL2 gC1qR/HABP1/p32 reactive oxygen species |
title | Complement protein C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma |
title_full | Complement protein C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma |
title_fullStr | Complement protein C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma |
title_full_unstemmed | Complement protein C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma |
title_short | Complement protein C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma |
title_sort | complement protein c1q stimulates hyaluronic acid degradation via gc1qr habp1 p32 in malignant pleural mesothelioma |
topic | hyaluronic acid hyaluronidase C1q HYAL2 gC1qR/HABP1/p32 reactive oxygen species |
url | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1151194/full |
work_keys_str_mv | AT andreabalduit complementproteinc1qstimulateshyaluronicaciddegradationviagc1qrhabp1p32inmalignantpleuralmesothelioma AT romanavidergar complementproteinc1qstimulateshyaluronicaciddegradationviagc1qrhabp1p32inmalignantpleuralmesothelioma AT paolazacchi complementproteinc1qstimulateshyaluronicaciddegradationviagc1qrhabp1p32inmalignantpleuralmesothelioma AT alessandromangogna complementproteinc1qstimulateshyaluronicaciddegradationviagc1qrhabp1p32inmalignantpleuralmesothelioma AT chiaraagostinis complementproteinc1qstimulateshyaluronicaciddegradationviagc1qrhabp1p32inmalignantpleuralmesothelioma AT micaelagrandolfo complementproteinc1qstimulateshyaluronicaciddegradationviagc1qrhabp1p32inmalignantpleuralmesothelioma AT cristinabottin complementproteinc1qstimulateshyaluronicaciddegradationviagc1qrhabp1p32inmalignantpleuralmesothelioma AT francescosalton complementproteinc1qstimulateshyaluronicaciddegradationviagc1qrhabp1p32inmalignantpleuralmesothelioma AT paolaconfalonieri complementproteinc1qstimulateshyaluronicaciddegradationviagc1qrhabp1p32inmalignantpleuralmesothelioma AT andrearocca complementproteinc1qstimulateshyaluronicaciddegradationviagc1qrhabp1p32inmalignantpleuralmesothelioma AT fabriziozanconati complementproteinc1qstimulateshyaluronicaciddegradationviagc1qrhabp1p32inmalignantpleuralmesothelioma AT fabriziozanconati complementproteinc1qstimulateshyaluronicaciddegradationviagc1qrhabp1p32inmalignantpleuralmesothelioma AT marcoconfalonieri complementproteinc1qstimulateshyaluronicaciddegradationviagc1qrhabp1p32inmalignantpleuralmesothelioma AT udaykishore complementproteinc1qstimulateshyaluronicaciddegradationviagc1qrhabp1p32inmalignantpleuralmesothelioma AT berhaneghebrehiwet complementproteinc1qstimulateshyaluronicaciddegradationviagc1qrhabp1p32inmalignantpleuralmesothelioma AT robertabulla complementproteinc1qstimulateshyaluronicaciddegradationviagc1qrhabp1p32inmalignantpleuralmesothelioma |